Schizophrenia

CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine [NA]

The study investigates accelerated transcranial magnetic stimulation as a treatment option for people with schizophrenia who are being treat…

CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)

A registered clinical registry evaluating treatment satisfaction and KarXT utilization in schizophrenia, currently recruiting.

CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder [Phase 1]

A Phase 1 clinical trial evaluating BXCL501 for efficacy and safety in agitation associated with pediatric schizophrenia and related disorde…

CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia [Phase 1, Phase 2]

A Phase 1/2 PET/MRI study of Cobenfy assessing dopamine transmission in schizophrenia and schizoaffective disorder, currently not yet recrui…

CLINICAL_TRIALS research · 2026-04-09

Clinical Trial Update: Paired Associative Stimulation in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia [NA]

This clinical trial update notes the status of a study evaluating paired associative stimulation of the dorsolateral prefrontal cortex in pa…

CLINICAL_TRIALS research · 2026-04-09

Clinical Trial Update: 52-week Open Label Safety-Tolerability Study [Phase 3]

LB Pharmaceuticals Inc. announced a 52-week open-label safety and tolerability study in schizophrenia patients (Phase 3), which is not yet r…

CLINICAL_TRIALS research · 2026-04-08

Clinical Trial Update: Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography

Completed clinical trial evaluating dopamine receptor function in healthy controls and patients with schizophrenia and schizoaffective disor…

CLINICAL_TRIALS research · 2026-04-07

Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN) [Phase 3]

This clinical trial update announces a Phase 3 study (EMERGENT TEEN) evaluating KarXT for schizophrenia in adolescents, with recruitment cur…

CLINICAL_TRIALS research · 2026-04-07

Clinical Trial Update: Synbiotic Compound to Reduce Symptoms of Schizophrenia [Phase 2]

A Phase 2 clinical trial evaluating a synbiotic compound to reduce symptoms of schizophrenia and schizoaffective disorder is currently recru…

CLINICAL_TRIALS research · 2026-04-07

Clinical Trial Update: Acetazolamide for Treatment Resistant Schizophrenia [Phase 1, Phase 2]

An ongoing Phase 1/2 clinical trial is evaluating acetazolamide for treatment-resistant schizophrenia, with recruitment currently ongoing.

CLINICAL_TRIALS research · 2026-04-03

Clinical Trial Update: Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia [Phase 3]

Phase 3 trial update showing Evenamide as an add-on to standard of care for schizophrenia in people with treatment-resistant schizophrenia; …

CLINICAL_TRIALS research · 2026-04-01

Clinical Trial Update: Ocrelizumab for Psychosis by Autoimmunity [Phase 1, Phase 2]

A Phase 1/2 clinical trial evaluating ocrelizumab as a treatment for autoimmune-related psychosis is currently recruiting.

CLINICAL_TRIALS research · 2026-04-01

Clinical Trial Update: A Study to Evaluate the Effect of KarXT on Urological Safety [Phase 4]

Phase 4 trial update examining the effect of KarXT on urological safety in people with schizophrenia; the study is currently recruiting.

CLINICAL_TRIALS research · 2026-03-31

Clinical Trial Update: Online Intervention To Improve Motivation [NA]

An online intervention to improve motivation for individuals at risk for schizophrenia and related psychosis is listed as not yet recruiting…

CLINICAL_TRIALS research · 2026-03-30

Clinical Trial Update: Effects of Brain Stimulation on Cognition, Oscillations and GABA Levels in Schizophrenia [NA]

A clinical trial investigating how brain stimulation affects cognition, neural oscillations, and GABA levels in schizophrenia; recruitment i…

CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: Incentives and Long-Acting Injectable Adherence After Involuntary Hospitalization [NA]

This clinical trial update from Stanford University concerns incentives and adherence to long-acting injectable medications after involuntar…

CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: Study of Language Disorders and Interactions Between Mnesic Capabilities and Semantic Competencies in Patients With Psychosis [NA]

A clinical trial recruiting to study language disorders and the interaction between memory capabilities and semantic skills in people with p…

CLINICAL_TRIALS research · 2026-03-25

Clinical Trial Update: A Bioequivalence Study of PP3M in Patients With Schizophrenia [NA]

A clinical trial update describing a bioequivalence study of PP3M in patients with schizophrenia, and the study is currently recruiting.

CLINICAL_TRIALS research · 2026-03-25

Clinical Trial Update: Sensory and Cognitive Predictions, and Their Disruptions in Schizophrenia [NA]

A clinical trial sponsored by Centre Psychothérapique de Nancy is studying sensory and cognitive predictions and their disruptions in schizo…

CLINICAL_TRIALS research · 2026-03-25

Clinical Trial Update: EEG and Behavioral Correlates of Temporal Prediction in the Tactile Modality in Schizophrenia [NA]

This ClinicalTrials.gov entry reports a study examining EEG and behavioral markers of temporal prediction in the tactile modality for schizo…